FG distributes 145 million insecticide nets in 6 years
Not less than 145 million long-lasting insecticidal nets (LLINs) have been distributed in 33 States in the last six years, the Federal Government has revealed.
It noted although the country could not achieve the pre-elimination it set out to achieve, marked reductions have been recorded in the malaria prevalence from 42 percent in 2010 to 27 percent in 2015 and 23 percent in 2018 based on the Nigeria Demographic and Health Survey (NDHS) results of 2018.
The National Coordinator of the National Malaria Elimination Programme (NMEP), Dr. Audu Mohammed, stated these in Abuja during a brief review on the extent of implementation of the Malaria Strategic Plan 2014 – 2020, which is due to expire by the end of the year.
He noted 130.42 million nets were distributed in mass replacement campaigns and over 16.3 million LLINs distributed through the routine system.
Audu observed that there have been increases in the utilisation of the nets by the most vulnerable population groups.
He said that the percentage of pregnant women who slept under ITN increased from 17 percent in 2013 to 49 percent in 2015 and rose to 58 percent in 2018, while the percentage of children under the age of five who slept under ITN increased from 16 percent in 2013 to 44 percent in 2015 and 52 percent in 2018.
He pointed out that there has been an increasing number of states with decreasing malaria burden below or equal to 15 percent.
The states are Lagos (2%); Imo (8%); Borno (10%); Rivers (11%); Bayelsa (13%); Benue (13%); Yobe (13%); Abia (14%); Nasarawa (14%) and Edo (15%).
He further stated that NMEP ensured the availability of quality anti-malarial commodities for all Nigerians based on limited resources.
From 2016 to 2019, he said, the programme provided over 92 million doses of ACTs (antimalarials), 22.5 million Sulfadoxine-Pyrimethamine (SP) doses and over 3 million vials of Artesunate Injection.
He added access to ACTs has improved significantly to 52 percent (2018 NDHS) from 18 percent in 2013 and the percentage of pregnant women who received IPT3 has increased from 5.5 percent (2013 NDHS) to 16.6 percent (2018 NDHS).